NewGenIvf Group Stock Price, News & Analysis

NewGenIvf Group (Nasdaq: NIVF) announced that subsidiary NewGenDigital signed an engagement letter effective October 30, 2025 to act as SAXA Inc.'s worldwide agent for tokenizing an initial US$100 million tranche of gold-backed assets.

The agreement is part one of a two-part transaction tied to a proposed reverse merger and includes an option to expand tokenization up to US$1 billion if the initial tranche completes. NewGenDigital will earn a 5% commission on assets sold, representing a potential revenue opportunity of about US$5 million. Services include SPV advisory, legal framework, blockchain implementation, and marketing.

NewGen (Nasdaq: NIVF) announced a non-binding term sheet for a proposed reverse merger with SAXA, Inc. to acquire mining assets via issuance of 500 million Class A shares at US$10 ($5.0B) and a planned additional 50 million shares at US$5 ($250M) for fundraising.

The deal would inject assets valued at ~US$11B, including NI 43-101 validated reserves of 1.9M oz gold and 4.4M oz silver, and a US$1.5B G.E.M.S. processing facility. Post-transaction, SAXA shareholders would hold 85.89% and nominate a majority of directors. Completion is subject to due diligence, financing, definitive agreement and approvals.

NewGen (Nasdaq: NIVF) entered a binding term sheet with White Lion to structure a Digital Assets Purchase Agreement allowing NewGen to receive up to 600,000 Solana (SOL) tokens (stated value: >$110 million) in exchange for shares over an initial 24-month period. Transactions are subject to definitive agreements and a registration statement to be filed immediately upon execution. NewGen launched its digital asset strategy in Dec 2024, established a Solana treasury in Jun 2025, and currently holds 13,000 SOL (~$2.5M).

NewGen (Nasdaq: NIVF) signed an engagement letter to act as worldwide agent to tokenize selected artworks from World Chinese Museum, converting ownership of physical pieces into blockchain-based digital tokens. The initial tranche is valued at US$2 million with a contractual provision to expand tokenization up to US$200 million if the rollout succeeds. NewGen will earn a 15% fee on the total value of tokenized assets. This deal follows NewGen’s prior US$30 million strategic investment in a Solana digital asset treasury and extends its push into digital finance and asset tokenization.

NewGen (NASDAQ:NIVF) announced that Zacks Small-Cap Research initiated equity research coverage on October 10, 2025. The announcement notes NewGen is a tech-forward, multi-jurisdictional growth company operating in real estate development, digital asset management and reproductive health solutions. The full Zacks equity research report is available on the Zacks website.

NewGen (NASDAQ: NIVF) formed a 60/40 joint venture with BNW to develop its Ras Al Khaimah Beach District plot in the UAE, targeting project completion in 2028. A BNW feasibility study estimates net returns up to US$67 million for NewGenProperty, a 272% return on investment, based on ~527,753 saleable sq ft at ~US$817/sq ft. Under the JVA NewGenProperty funds 36% of the plot purchase price and is entitled to 36% of gross sales revenue with deductions for up to 10% agent fees, 2% BNW marketing fees, and reimbursements for any developer-paid balance. BNW will cover construction, management, and a share of marketing/brokerage costs, reducing NewGen’s upfront cash needs and diversifying revenue away from fertility services.

NewGen (NASDAQ: NIVF) received an independent valuation that sets the fair value of acquired advanced cytometry IP at US$17.9 million, part of an acquisition announced July 29, 2025. Combined with equipment and other assets, the deal produced a Bargain Purchase Gain of US$19.2 million and increased the company's NAV by about US$8.9 per share as of Oct. 6, 2025. The company said the gain should materially boost year‑end net profit.

NewGen describes the acquisition as a strategic pivot from traditional IVF services toward a technology-driven, capital-light model that targets licensing, royalties, and consumables sales. The company is pursuing necessary regulatory approvals and building an in‑house R&D team to commercialize the platform.

NewGenIvf Group Limited (NASDAQ: NIVF) has announced a strategic acquisition of advanced cytometry technology and assets to support its U.S. market expansion. The acquisition includes 18 fully-constructed cell-sorting systems, 8 partially constructed units, and 6 patents related to microfluidic systems.

The technology enhances NewGen's NewGenSort service, which enables X and Y chromosome sperm cell separation for IVF procedures. The company projects processing capability of over 25,000 sorts annually, targeting less than 6% of total U.S. IVF cycles. Based on conservative estimates, NewGen anticipates annual gross revenue exceeding $20 million from U.S. operations once fully operational.

The technology rollout is planned for Q1 2026, targeting the growing U.S. fertility market, which recorded 432,641 IVF cycles and 95,860 IVF births in 2023.

NewGenIvf Group (NASDAQ: NIVF) announced that its subsidiary NewGenDigital has signed an MOU with BNW Real Estate Development, a prominent UAE developer, to form a joint venture for developing NewGenDigital's plot in Ras Al Khaimah's Beach District.

Under the agreement, BNW will oversee project execution, management, sales, and marketing, covering all construction costs and partial marketing expenses. NewGenDigital will contribute 36% of the initial land cost (approximately $24M) and receive 36% of gross sales revenue. According to BNW's feasibility study, the project could generate a potential net return of $67 million, representing a 272% return on investment.

The development plans include a 527,753 square feet saleable area, with an estimated sale price of AED3,000 per square foot ($817).